A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf
.
Maggot Debridement Therapy (MDT) for Treatment of Cutaneous Leishmaniasis Wound using Lucilia serricata Larvae in Iran: Case Reports
2022
Journal of Advances in Medical and Biomedical Research
Leishmaniasis is a worldwide vector-borne disease. The Cutaneous form of this disease leaves chronic wounds on the patient's skin. The purpose of this study was to treat cutaneous leishmaniasis woundsusing Lucilia serricata larvae. Leishman's body was confirmed and Leishmania major was identified using PCR test in the samples of three patients in health center of Andimeshk County, southwest Iran during 2019-2020. The patients signed an informed consent form to receive maggot therapy. Five to
doi:10.30699/jambs.30.e56641
fatcat:eoamvovut5bt5o4hgxs7h7hjpa